Jastrebarsko, Croatia

Dijana Škalec Šamec

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Dijana Škalec Šamec: Pioneering Pharmaceutical Advancements

Introduction

Dijana Škalec Šamec is a notable inventor based in Jastrebarsko, Croatia. She has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. Her work focuses on the development of solid-state forms of various compounds, which are crucial for enhancing drug efficacy and stability.

Latest Patents

Dijana's latest patents include innovative formulations such as solid-state forms of n-[2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4H-chromene-2-carboxamide and its mesylate salt. This patent relates to the solid-state forms of Encequidar (previously referred to as HM-30181A) base, as well as its mesylate and co-crystals, including processes for their preparation and pharmaceutical compositions. Another significant patent involves crystalline Lorlatinib: fumaric acid and its solid-state forms, detailing processes for preparation and methods of use.

Career Highlights

Throughout her career, Dijana has worked with prominent companies such as Assia Chemical Industries Ltd. and Tapi Croatia Industries Ltd. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical development and innovation.

Collaborations

Dijana has collaborated with various professionals in her field, including her coworker Lorena Kordić. Their joint efforts have contributed to the advancement of pharmaceutical formulations and solid-state chemistry.

Conclusion

Dijana Škalec Šamec stands out as a pioneering inventor in the pharmaceutical industry, with her innovative patents and collaborations driving advancements in drug formulation. Her contributions are vital for the ongoing development of effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…